Propanc Biopharma, Inc. (PPCB)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Amended Registration Statement on Form S-1, which was filed on May 30, 2025. They are see… | Read Filing EDGAR |
| Aug. 12, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. is a request for the acceleration of the effective date of their Registration Statement on Form S-1. D. Boral Capital LLC, represen… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. is a request for the acceleration of the effective date of their Registration Statement on Form S-1. D. Boral Capital LLC, represen… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has submitted a request to the SEC for the effectiveness of their Amended Registration Statement on Form S-1, which was filed on May 30, 2025. They are see… | Read Filing EDGAR |
| Jul. 29, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effective date of its Registration Statement on Form S-1. This de… | Read Filing EDGAR |
| Jul. 29, 2025 | CORRESP | Neutral/Informational | Low | Propanc Biopharma, Inc. has formally requested the withdrawal of its previous request for the acceleration of the effectiveness of its Registration Statement on Form S-1. Initiall… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Propanc Biopharma, Inc. to the SEC is a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request is made… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Moderate | Propanc Biopharma, Inc. has submitted a request to the SEC to make their Amendment No. 5 to Registration Statement on Form S-1 effective on July 28, 2025. The company has authoriz… | Read Filing EDGAR |